International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-3
Original Article
A Comparative Study on the Efficacy of 3D Reconstruction Over 2D CT Images in Detecting Facial Fractures
 ,
 ,
 ,
 ,
 ,
 ,
Published
June 30, 2025
Abstract

Background: Facial trauma is increasingly prevalent, necessitating accurate diagnostic tools like computed tomography (CT). Three-dimensional (3D) reconstruction offers potential advantages over two-dimensional (2D) imaging in evaluating complex fractures.

Objective: This study assessed the efficacy of 3D reconstruction compared to 2D axial CT images in detecting, delineating the extent, and assessing displacement of facial fractures.

Methods: A comparative study was conducted on 60 patients with history of facial trauma at SSIMS & RC, Davangere, from January 2023 to June 2025. CT scans were performed using a GE Optima 128-slice machine, with 2D axial images reconstructed into 3D volume-rendered images. Efficacy was evaluated across five regions (frontal, zygomatic, naso-orbito-ethmoidal, maxillary, mandibular) using a scoring system (1=inferior, 2=similar, 3=superior with rapid assimilation, 4=superior with additional information). Data were analyzed using SPSS software.
Results: Of 60 patients, 93% were male, with a mean age of 34.2 years (SD 15.1). Maxillary fractures were most common (60%). 3D imaging was superior in detecting mandibular fractures (80%, score=3) and assessing displacement in zygomatic fractures (73.9%, score≥3), but inferior for naso-orbito-ethmoidal fracture detection (43.75%, score=1). Statistical significance was noted in mandibular displacement assessment (p=0.02).

Conclusion: 3D reconstruction enhances detection and displacement assessment in specific facial fractures, notably mandibular and zygomatic, but is less effective for thin-boned regions like naso-orbito-ethmoidal fractures.

Recommended Articles
Loading Image...
Volume-6, Issue-3
Citations
2276 Views
229 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved